InvestorsHub Logo
Followers 516
Posts 38725
Boards Moderated 5
Alias Born 04/26/2012

Re: None

Sunday, 07/08/2018 9:09:39 AM

Sunday, July 08, 2018 9:09:39 AM

Post# of 4204
Massive for all who are new to ARYC:

Arrayit CLIA clinical team confirms 7/2/2018 meeting with top officials at the United States Food and Drug Administration FDA headquartered in Silver Spring Maryland USA to discuss FDA regulatory clearance of a major microarray technology product line fda.gov

Arrayit has developed an advanced blood card technology that collects and fractionates whole blood into red blood cells, white blood cells and serum components quickly, easily and affordably. Our unique linear separation chromatography process collects 5 droplets of whole blood and separates and dries the whole blood components in 10 minutes. Arrayit Blood Cards can be used to fractionate, ship, sample and store samples for a variety of applications in research, veterinary medicine and pathology including protein-based allergy testing and cancer research. Arrayit Blood Cards can also be used to isolate DNA and mRNA samples for genotyping and expression profiling applications. Private labeling is available for large OEM accounts.

http://www.arrayit.com/Microarray_Diagnostics/Blood_Cards/blood_cards.html

July 2 is just a couple weeks away

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.